Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation-Reference-Cited by-同舟云学术

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Published:2011-09-08 Issue:10 Volume:365 Page:883-891
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Patel Manesh R.,Mahaffey Kenneth W.,Garg Jyotsna,Pan Guohua,Singer Daniel E.,Hacke Werner,Breithardt Günter,Halperin Jonathan L.,Hankey Graeme J.,Piccini Jonathan P.,Becker Richard C.,Nessel Christopher C.,Paolini John F.,Berkowitz Scott D.,Fox Keith A.A.,Califf Robert M.,

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1009638

Cited by 7813 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry;Archives of Gerontology and Geriatrics;2025-01

2. An accurate haplotyping method using multiplex pyrosequencing with AS-PCR to detect ABCB1 haplotypes associated with rivaroxaban-derived hemorrhagic events;Talanta;2025-01

3. The use of reduced DOAC doses in atrial fibrillation patients does not always lead to good anticoagulation levels and avoid adverse events;International Journal of Cardiology;2024-12

4. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design;American Heart Journal;2024-11

5. Left atrial appendage thrombus is associated with a higher fractal dimension in patients with atrial fibrillation;Clinical Imaging;2024-10